Allison Fitzgerald: What We Know About CVID and Lymphoma Risk
Allison Fitzgerald/LinkedIn

Allison Fitzgerald: What We Know About CVID and Lymphoma Risk

Allison Fitzgerald, Hematology/Oncology Clinical Fellow at Dana-Farber Cancer Institute, shared a post on X:

“Today I learned common variable immunodeficiency, the most common primary immunodeficiency is adults, is associated with a ~10 fold increase risk of cancer, commonly B cell lymphomas.

In contrast, IgA deficiency doesn’t have as clear of an association with increased lymphoma risk.”

Other articles about lymphoma on OncoDaily.